To the Editor We read with interest the article outlining the 2016 mSMART guidelines for the diagnosis and management of Waldenström macroglobulinemia (WM). We believe that this is a unique opportunity to emphasize important differences that exist with WM therapy.
http://ift.tt/2EwhLRg
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου